Company Overview of RainDance Technologies, Inc.
RainDance Technologies, Inc. develops genomic tools for non-invasive liquid biopsy applications for the research, early detection, and treatment of cancer, inherited, and infectious diseases. It offers RainDrop, a digital polymerase chain reaction (PCR) solution; ThunderStorm, a targeted DNA sequencing system; ThunderBolts Cancer Panel, a DNA sequencing (NGS) solution that enables researchers to profile a range of tumor samples; peer-reviewed articles, including digital PCR, targeted DNA sequencing, and microdroplet applications articles, as well as technology reviews; and scientific posters, such as digital PCR and targeted DNA sequencing posters. The company serves major academic research ...
749 Middlesex Turnpike
Billerica, MA 01821
Founded in 2004
Key Executives for RainDance Technologies, Inc.
Co-Founder and Chief Technology Officer
Compensation as of Fiscal Year 2014.
RainDance Technologies, Inc. Key Developments
RainDance Technologies, Inc. Appoints Kathy Ordonez to Board of Directors
Jul 16 14
RainDance Technologies, Inc. announced the appointment of Kathy Ordoñez to its Board of Directors. Kathy Ordonez brings more than 30 years of experience in the life sciences and diagnostics industries. Ms. Ordonez was previously the Chief Executive Officer at Celera and a founder of Celera Diagnostics.
RainDance Technologies, Inc. Announces Availability of its ThunderBolts(TM) Cancer Panel
Apr 7 14
RainDance Technologies, Inc. announced the availability of its ThunderBolts(TM) Cancer Panel, a comprehensive next-generation DNA sequencing (NGS) solution that enables researchers to profile a wide range of tumor samples in fewer than two days for as low as $100 per sample. During this week's American Association for Cancer Research (AACR) Annual Meeting, several prominent cancer researchers and collaborators in RainDance's First Access Program (FAP) will present their latest findings demonstrating the product's high sensitivity, low starting sample requirements and simple workflow in breast, colorectal, esophageal, and pancreatic cancer studies. These leading researchers will share their data and experience using the ThunderBolts Cancer Panel for profiling tumor samples and the RainDrop Digital(TM) PCR System for follow-up mutation validation. The ThunderBolts Cancer Panel targets 50 important and well known cancer genes, including the content found on the Ion Torrent AmpliSeq(TM) Cancer Hotspot Panel v2 and Illumina TruSeq(R) Amplicon Cancer Panel products. The panel features a fast, simple workflow that is optimized for Illumina NGS systems and compatible with FFPE samples with as low as 10 ng of starting DNA. The panel runs on the same compact $50,000 RainDrop Source Instrument and consumables as the RainDrop Digital PCR System. Researchers gain rapid, accurate cancer mutation profiles for as low as $100 per sample.
RainDance Technologies, Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-13-2014 02:30 PM
Feb 4 14
RainDance Technologies, Inc. Presents at 2014 Leerink Swann Global Healthcare Conference, Feb-13-2014 02:30 PM. Venue: The Waldorf Astoria Hotel, New York, New York, United States. Speakers: Alfred G. Merriweather, Chief Financial Officer, Roopom Bannerjee, President and CEO.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|